Relationship Between B-Vitamin Biomarkers and Dietary Intake with Apolipoprotein E є4 in Alzheimer’s Disease

Nathan M. D’Cunha, Ekavi N. Georgousopoulou, Lyndell Boyd, Martin Veysey, Jonathan Sturm, Bill O’Brien, Mark Lucock, Andrew J. McKune, Duane D. Mellor, Paul D. Roach, Nenad Naumovski

Research output: Contribution to journalArticle

Abstract

The potential for B-vitamins to reduce plasma homocysteine (Hcy) and reduce the risk of Alzheimer’s disease (AD) has been described previously. However, the role of Apolipoprotein E є4 (APOE4) in this relationship has not been adequately addressed. This case-control study explored APOE4 genotype in an Australian sample of 63 healthy individuals (female = 38; age = 76.9 ± 4.7 y) and 63 individuals with AD (female = 35, age = 77.1 ± 5.3 y). Findings revealed 55 of 126 participants expressed the APOE4 genotype with 37 of 126 having both AD and the APOE4 genotype. Analysis revealed an increased likelihood of AD when Hcy levels are >11.0 µmol/L (p = 0.012), cysteine levels were <255 µmol/L (p = 0.033) and serum folate was <22.0 nmol/L (p = 0.003; in males only). In females, dietary intake of total folate <336 µg/day (p=0.001), natural folate <270 µg/day (p = 0.011), and vitamin B2 < 1.12 mg/day (p = 0.028) was associated with an increased AD risk. These results support Hcy, Cys, and SF as useful biomarkers for AD, irrespective of APOE4 genotype and as such should be considered as part of screening and managing risk of AD.

Original languageEnglish
Pages (from-to)1-23
Number of pages23
JournalJournal of Nutrition in Gerontology and Geriatrics
DOIs
Publication statusE-pub ahead of print - 1 Jan 2019

Fingerprint

Apolipoprotein E4
Vitamin B Complex
Alzheimer Disease
Biomarkers
Homocysteine
Genotype
Folic Acid
Riboflavin
Cysteine
Case-Control Studies
Serum

Cite this

D’Cunha, Nathan M. ; Georgousopoulou, Ekavi N. ; Boyd, Lyndell ; Veysey, Martin ; Sturm, Jonathan ; O’Brien, Bill ; Lucock, Mark ; McKune, Andrew J. ; Mellor, Duane D. ; Roach, Paul D. ; Naumovski, Nenad. / Relationship Between B-Vitamin Biomarkers and Dietary Intake with Apolipoprotein E є4 in Alzheimer’s Disease. In: Journal of Nutrition in Gerontology and Geriatrics. 2019 ; pp. 1-23.
@article{c9c6c9f394294223ab4a951a85e20ea7,
title = "Relationship Between B-Vitamin Biomarkers and Dietary Intake with Apolipoprotein E є4 in Alzheimer’s Disease",
abstract = "The potential for B-vitamins to reduce plasma homocysteine (Hcy) and reduce the risk of Alzheimer’s disease (AD) has been described previously. However, the role of Apolipoprotein E є4 (APOE4) in this relationship has not been adequately addressed. This case-control study explored APOE4 genotype in an Australian sample of 63 healthy individuals (female = 38; age = 76.9 ± 4.7 y) and 63 individuals with AD (female = 35, age = 77.1 ± 5.3 y). Findings revealed 55 of 126 participants expressed the APOE4 genotype with 37 of 126 having both AD and the APOE4 genotype. Analysis revealed an increased likelihood of AD when Hcy levels are >11.0 µmol/L (p = 0.012), cysteine levels were <255 µmol/L (p = 0.033) and serum folate was <22.0 nmol/L (p = 0.003; in males only). In females, dietary intake of total folate <336 µg/day (p=0.001), natural folate <270 µg/day (p = 0.011), and vitamin B2 < 1.12 mg/day (p = 0.028) was associated with an increased AD risk. These results support Hcy, Cys, and SF as useful biomarkers for AD, irrespective of APOE4 genotype and as such should be considered as part of screening and managing risk of AD.",
keywords = "Aged, aging, Alzheimer disease, apolipoprotein E, cysteine, dementia, elderly, folate, folic acid, homocysteine, nutritional vulnerability",
author = "D’Cunha, {Nathan M.} and Georgousopoulou, {Ekavi N.} and Lyndell Boyd and Martin Veysey and Jonathan Sturm and Bill O’Brien and Mark Lucock and McKune, {Andrew J.} and Mellor, {Duane D.} and Roach, {Paul D.} and Nenad Naumovski",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/21551197.2019.1590287",
language = "English",
pages = "1--23",
journal = "Journal of Nutrition for the Elderly",
issn = "0163-9366",
publisher = "Routledge",

}

Relationship Between B-Vitamin Biomarkers and Dietary Intake with Apolipoprotein E є4 in Alzheimer’s Disease. / D’Cunha, Nathan M.; Georgousopoulou, Ekavi N.; Boyd, Lyndell; Veysey, Martin; Sturm, Jonathan; O’Brien, Bill; Lucock, Mark; McKune, Andrew J.; Mellor, Duane D.; Roach, Paul D.; Naumovski, Nenad.

In: Journal of Nutrition in Gerontology and Geriatrics, 01.01.2019, p. 1-23.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Relationship Between B-Vitamin Biomarkers and Dietary Intake with Apolipoprotein E є4 in Alzheimer’s Disease

AU - D’Cunha, Nathan M.

AU - Georgousopoulou, Ekavi N.

AU - Boyd, Lyndell

AU - Veysey, Martin

AU - Sturm, Jonathan

AU - O’Brien, Bill

AU - Lucock, Mark

AU - McKune, Andrew J.

AU - Mellor, Duane D.

AU - Roach, Paul D.

AU - Naumovski, Nenad

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The potential for B-vitamins to reduce plasma homocysteine (Hcy) and reduce the risk of Alzheimer’s disease (AD) has been described previously. However, the role of Apolipoprotein E є4 (APOE4) in this relationship has not been adequately addressed. This case-control study explored APOE4 genotype in an Australian sample of 63 healthy individuals (female = 38; age = 76.9 ± 4.7 y) and 63 individuals with AD (female = 35, age = 77.1 ± 5.3 y). Findings revealed 55 of 126 participants expressed the APOE4 genotype with 37 of 126 having both AD and the APOE4 genotype. Analysis revealed an increased likelihood of AD when Hcy levels are >11.0 µmol/L (p = 0.012), cysteine levels were <255 µmol/L (p = 0.033) and serum folate was <22.0 nmol/L (p = 0.003; in males only). In females, dietary intake of total folate <336 µg/day (p=0.001), natural folate <270 µg/day (p = 0.011), and vitamin B2 < 1.12 mg/day (p = 0.028) was associated with an increased AD risk. These results support Hcy, Cys, and SF as useful biomarkers for AD, irrespective of APOE4 genotype and as such should be considered as part of screening and managing risk of AD.

AB - The potential for B-vitamins to reduce plasma homocysteine (Hcy) and reduce the risk of Alzheimer’s disease (AD) has been described previously. However, the role of Apolipoprotein E є4 (APOE4) in this relationship has not been adequately addressed. This case-control study explored APOE4 genotype in an Australian sample of 63 healthy individuals (female = 38; age = 76.9 ± 4.7 y) and 63 individuals with AD (female = 35, age = 77.1 ± 5.3 y). Findings revealed 55 of 126 participants expressed the APOE4 genotype with 37 of 126 having both AD and the APOE4 genotype. Analysis revealed an increased likelihood of AD when Hcy levels are >11.0 µmol/L (p = 0.012), cysteine levels were <255 µmol/L (p = 0.033) and serum folate was <22.0 nmol/L (p = 0.003; in males only). In females, dietary intake of total folate <336 µg/day (p=0.001), natural folate <270 µg/day (p = 0.011), and vitamin B2 < 1.12 mg/day (p = 0.028) was associated with an increased AD risk. These results support Hcy, Cys, and SF as useful biomarkers for AD, irrespective of APOE4 genotype and as such should be considered as part of screening and managing risk of AD.

KW - Aged

KW - aging

KW - Alzheimer disease

KW - apolipoprotein E

KW - cysteine

KW - dementia

KW - elderly

KW - folate

KW - folic acid

KW - homocysteine

KW - nutritional vulnerability

UR - http://www.scopus.com/inward/record.url?scp=85063583909&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/relationship-between-bvitamin-biomarkers-dietary-intake-apolipoprotein-e-%D1%944-alzheimers-disease

U2 - 10.1080/21551197.2019.1590287

DO - 10.1080/21551197.2019.1590287

M3 - Article

SP - 1

EP - 23

JO - Journal of Nutrition for the Elderly

JF - Journal of Nutrition for the Elderly

SN - 0163-9366

ER -